| Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use V Wilkinson, K Takano, D Nichols, A Martin, R Holme, D Phalen, ... Parasites & vectors 14, 1-21, 2021 | 25 | 2021 |
| Drug dose and animal welfare: important considerations in the treatment of wildlife K Mounsey, RJ Harvey, V Wilkinson, K Takano, J Old, H Stannard, ... Parasitology research 121 (3), 1065-1071, 2022 | 8 | 2022 |
| Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife K Takano, L De Hayr, S Carver, RJ Harvey, KE Mounsey International Journal for Parasitology: Drugs and Drug Resistance 21, 97-113, 2023 | 6 | 2023 |
| Assessment of the in vitro acaricidal activity of Bravecto® (fluralaner) and a proposed orange oil-based formulation vehicle for the treatment of Sarcoptes scabiei K Takano, S Carver, Y Vermaak, K Fischer, RJ Harvey, KE Mounsey Parasites & Vectors 17 (1), 194, 2024 | | 2024 |
